An Integrated Approach to PMS

By Critical Software

With the entry into force of the Medical Device Regulation (EU 2017/745 MDR) on 26 May 2021, several medical device manufacturers have been updating their post-market surveillance (PMS) processes in their Quality Management System (QMS) in order to comply with the new requirements.

For companies developing software as a medical device (SaMD) and/or devices with software (SW) components, the new categorisation of the software risk class (rule 11 in MDR) has also resulted in additional PMS activities. Understanding the PMS requirements is essential for a manufacturer to be able to monitor the safety and performance of devices placed on the market and ensure compliance with the regulation.

To learn more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.